Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: A phase II study

被引：53

作者：

Buckley, Colin ^{[1
]}

Hoffmann, Vibeke ^{[2
]}

Shapiro, Jerry ^{[4
]}

Saari, Seppo ^{[5
]}

Cambazard, Frederic ^{[6
]}

Milsgaard, Mette ^{[3
]}

机构：

[1] Waterford Reg Hosp Ardkeen, Dept Dermatol, Waterford, Ireland

[2] LEO Pharma AS, Clin Operat, Bellerup, Denmark

[3] LEO Pharma AS, Dept Biostat, Bellerup, Denmark

[4] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada

[5] Med Recept Ctr, Policlin Dermatol, Turku, Finland

[6] CHU St Etienne, Hop Nord, Serv Dermatol, St Etienne, France

来源：

DERMATOLOGY | 2008年 / 217卷 / 02期

关键词：

betamethasone dipropionate plus calcipotriol; scalp formulation; phase II study; scalp psoriasis; topical treatment;

D O I：

10.1159/000130425

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 [皮肤病与性病学];

摘要：

Background: There is a need for more effective therapy for scalp psoriasis. Objective: To assess the efficacy and safety of a 2-compound scalp formulation including calcipotriol and betamethasone dipropionate in the treatment of scalp psoriasis. Methods: Patients (n=218) with scalp psoriasis were randomized to treatment with the 2-compound scalp formulation (n=108) or betamethasone dipropionate in the same vehicle (n=110). The treatments were applied once daily on the scalp for up to 8 weeks. Results: The 2-compound scalp formulation showed a significantly higher efficacy than betamethasone dipropionate on the total sign score at the end of treatment (p=0.042)and after 2 weeks (p=0.005). Conclusion: The calcipotriol plus betamethasone dipropionate scalp formulation was superior to betamethasone dipropionate in the same vehicle when used once daily for up to 8 weeks in the treatment of scalp psoriasis. Copyright (c) 2008 S. Karger AG, Basel.

引用

页码：107 / 113

页数：7

共 26 条

[1]

Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany [J].

Augustin, M. ;

Peeters, P. ;

Radtke, M. ;

Moehling, U. ;

Lapp, C. .

DERMATOLOGY, 2007, 215 (03) :219-228

[2]

Barnes L, 2000, EUR J DERMATOL, V10, P199

[3]

A MULTICENTER, PARALLEL-GROUP COMPARISON OF CALCIPOTRIOL OINTMENT AND SHORT-CONTACT DITHRANOL THERAPY IN CHRONIC PLAQUE PSORIASIS [J].

BERTHJONES, J ;

CHU, AC ;

DODD, WAH ;

GANPULE, M ;

GRIFFITHS, WAD ;

HAYDEY, RP ;

KLABER, MR ;

MURRAY, SJ ;

ROGERS, S ;

JURGENSEN, HJ .

BRITISH JOURNAL OF DERMATOLOGY, 1992, 127 (03) :266-271

[4]

COMPARATIVE-STUDY OF CALCIPOTRIOL (MC-903) OINTMENT AND BETAMETHASONE 17-VALERATE OINTMENT IN PATIENTS WITH PSORIASIS-VULGARIS [J].

CUNLIFFE, WJ ;

BERTHJONES, J ;

CLAUDY, A ;

FAIRISS, G ;

GOLDIN, D ;

GRATTON, D ;

HENDERSON, CA ;

HOLDEN, CA ;

MADDIN, WS ;

ORTONNE, JP ;

YOUNG, M ;

ADAM, JE ;

DODD, WA ;

RAMSAY, CA ;

AMBLARD, P ;

BONNETBLANC, JM ;

BOZZETTO, G ;

DENOEUX, JP ;

GUIDONI, JF ;

GUILHOU, JJ ;

LAROCHE, L ;

LAURET, P ;

LEPEYTRE, P ;

MOULIN, G ;

NOBLE, JP ;

PASQUIOU, C ;

SCHUBERT, B ;

VERRET, JL ;

POWELL, F ;

OLOUGHLIN, S ;

LYONS, F ;

CHALMERS, RJG ;

CHU, AC ;

ROWELL, NR ;

ELLIS, JP ;

FOULDS, I ;

GRIFFITHS, WAD ;

HARRINGTON, CI ;

HARRISON, PV ;

HUTCHINSON, PE ;

KLABER, MR ;

LOVELL, CR ;

MCGIBBON, DH ;

MILLER, JA ;

MISCH, KJ ;

PRICE, M ;

SAIHAN, EM ;

SHAMY, HK ;

VOLLUM, DI ;

WONG, E .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (05) :736-743

[5]

A new calcipotriol/beta methasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris [J].

Douglas, WS ;

Poulin, Y ;

Decroix, J ;

Ortonne, JP ;

Mrowietz, U ;

Gulliver, W ;

Krogstad, AL ;

Larsen, FG ;

Iglesias, L ;

Buckley, C ;

Bibby, AJ .

ACTA DERMATO-VENEREOLOGICA, 2002, 82 (02) :131-135

[6]

ELLIS JP, 1995, EUR J CLIN RES, V7, P247

[7]

PSORIASIS - A QUESTIONNAIRE SURVEY OF 2144 PATIENTS [J].

FARBER, EM ;

BRIGHT, RD ;

NALL, ML .

ARCHIVES OF DERMATOLOGY, 1968, 98 (03) :248-&

[8]

NATURAL-HISTORY OF PSORIASIS IN 5,600 PATIENTS [J].

FARBER, EM ;

NALL, ML .

DERMATOLOGICA, 1974, 148 (01) :1-18

[9]

Patients' vehicle preference for corticosteroid treatments of scalp psoriasis [J].

Feldman, SR ;

Housman, TS .

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2003, 4 (04) :221-224

[10]

COMPARATIVE EFFECTS OF CALCIPOTRIOL (MC903) SOLUTION AND PLACEBO (VEHICLE OF MC903) IN THE TREATMENT OF PSORIASIS OF THE SCALP [J].

GREEN, C ;

GANPULE, M ;

HARRIS, D ;

KAVANAGH, G ;

KENNEDY, C ;

MALLETT, R ;

RUSTIN, M ;

DOWNES, N .

BRITISH JOURNAL OF DERMATOLOGY, 1994, 130 (04) :483-487

← 1 2 3 →